Trials / Unknown
UnknownNCT01564979
Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Khon Kaen University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether pretarsal and preseptal techniques of Botulinum toxin type A injection have any effect on tear functions.
Detailed description
Botulinum toxin type A has been used for hemifacial spasm since 1986. of Botulinum toxin type A can be subcutaneously injected at pretarsal or preseptal portion of orbicularis muscle. Blepharoptosis has been reported less frequently with pretarsal technique, however dry eye was noticed in one patient treated with pretarsal botulinum toxin type A for cosmetic purpose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | preseptal injection of botulinum toxin type A | botulinum toxin type A (Botox)2.5 units, 5 points |
| DRUG | pretarsal injection of Botulinum toxin type A | Botulinum toxin type A 2,5 units, 5 points |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-09-01
- Completion
- 2012-12-01
- First posted
- 2012-03-28
- Last updated
- 2012-03-28
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01564979. Inclusion in this directory is not an endorsement.